Evidence map›Paper›PMID 34192410›Full record

ArticleJournal of thrombosis and haemostasis : JTH2021

Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth.

Bal Krishan Sharma, Duaa Mureb, Sumit Murab, Leah Rosenfeldt, Brenton Francisco, Rachel Cantrell, Rebekah Karns, Lindsey Romick-Rosendale, Miki Watanabe-Chailland, Eleanor M Mast and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
  8. Article
  9. Article
  10. Fibrinogen and tumors.Frontiers in oncology · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Bal Krishan SharmaCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Duaa MurebCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Sumit MurabDivision of Orthopaedics Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Leah RosenfeldtCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Brenton FranciscoCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.ORCID 0000-0003-0403-9845
Rachel CantrellCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Rebekah KarnsDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Lindsey Romick-RosendaleDivision of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Miki Watanabe-ChaillandDivision of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Eleanor M MastCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Matthew J FlickDepartment of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Patrick W WhitlockDivision of Orthopaedics Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Joseph S PalumboCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma diseaseR01CA211098 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2017 to 2022
$2.2M
Hemostatic Factors Drive Prostate Cancer PathogenesisR01CA193678 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI PALUMBO, JOSEPH S. · 2016 to 2020
$1.8M
Coagulation factors as modifiers of the colon cancer microenvironmentR01CA204058 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI PALUMBO, JOSEPH S. · 2016 to 2020
$1.8M
Pathogenesis and therapeutic targeting of immune disordersT32AI118697 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2016 to 2020
$683k
NCI NIH HHS R01 CA193678NCI NIH HHS R01 CA204058NCI NIH HHS R01 CA211098NIAID NIH HHS T32 AI118697NIDDK NIH HHS P30 DK078392
6 · The paper itself

Abstract

backgroundWe previously showed that fibrinogen is a major determinant of the growth of a murine model of colorectal cancer (CRC).

objectiveOur aim was to define the mechanisms coupling fibrin(ogen) to CRC growth.

resultsCRC tumors transplanted into the dorsal subcutis of Fib

conclusionsThese studies suggest that fibrin(ogen) is an important component of the colon cancer microenvironment and may be exploited as a potential therapeutic target.

Indexed as

AdenocarcinomaColorectal NeoplasmsFibrinogenFocal Adhesion Kinase 1AnimalsHemostaticsMiceTumor MicroenvironmentFibrinogenFocal Adhesion Kinase 1HemostaticsPtk2 protein, mouse14-3-3σcell senescencecolorectal adenocarcinomaFibrinogenfocal adhesion kinasep53

Identifiers

PMID34192410
PMCPMC8493761
OpenAlexW3174842974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.